Lucid Diagnostics (LUCD) Financial Statements

Compare

586 Followers

Lucid Diagnostics Financial Overview

Lucid Diagnostics's market cap is currently $198.18M. The company's EPS TTM is $-0.1; its P/E ratio is >-0.01; Lucid Diagnostics is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 4.71B	$ 4.35M	$ 2.43M	$ 377.00K	$ 500.00K
Gross Profit	$ -1.96B	$ -3.92M	$ -6.05M	$ -3.24M	$ -85.00K
Operating Income	$ -49.64B	$ -46.05M	$ -48.48M	$ -56.17M	$ -27.42M
EBITDA	$ -48.77M	$ -44.34M	$ -49.75M	$ -54.23M	$ -27.41M
Net Income	$ -70.57B	$ -45.53M	$ -52.67M	$ -56.17M	$ -28.08M
Balance Sheet
Cash & Short-Term Investments	$ 34.70B	$ 22.36M	$ 18.90M	$ 22.47M	$ 53.66M
Total Assets	$ 40.45B	$ 30.71M	$ 27.27M	$ 32.51M	$ 59.00M
Total Debt	$ 25.82B	$ 21.25M	$ 15.26M	$ 2.00M	$ 0.00
Net Debt	$ -8.88B	$ -1.10M	$ -3.64M	$ -20.48M	$ -53.66M
Total Liabilities	$ 29.51B	$ 25.32M	$ 29.58M	$ 9.46M	$ 4.26M
Stockholders' Equity	$ 10.94B	$ 5.39M	$ -2.31M	$ 23.05M	$ 54.74M
Cash Flow
Free Cash Flow	$ -46.48B	$ -44.79M	$ -33.04M	$ -30.59M	$ -18.53M
Operating Cash Flow	$ -46.48B	$ -44.14M	$ -32.82M	$ -29.68M	$ -17.67M
Investing Cash Flow	$ -197.00M	$ -646.00K	$ -221.00K	$ -4.11M	$ -862.00K
Financing Cash Flow	$ 59.03B	$ 48.25M	$ 29.46M	$ 2.61M	$ 72.08M

Currency in USD

Lucid Diagnostics Earnings and Revenue History

Income Statement >

Lucid Diagnostics Debt to Assets

Balance Sheet >

Lucid Diagnostics Cash Flow

Cash Flow >

Lucid Diagnostics Forecast EPS vs Actual EPS

Earnings >